EUROPE: +33 (0) 972 476 029 - USA: +1 (617) 553-9294

The latest news on Genoskin

Check our latest news below. For more info - contact us!

Contact us

We are hiring! Join our team as a Lab Assistant in Toulouse!

  4 August 2022

Read more

Immunocompetent human skin for vaccine and drug development

  31 May 2022

Read more

Dr. Ginhoux joins Genoskin Scientific Advisory Board

  12 May 2022

Read more

Myeloid Cell Profiling – Naked Immunology Webinar 2

  27 April 2022

Read more

Naked Immunology – Webinar 1 – MRGPRX2+ Mast Cells

  18 February 2022

Read more

What I Learned In A French Lab That Led To My Role As A CEO

  11 February 2022

Read more

Genoskin CSO obtains high-profile career award

  4 January 2022

Read more

Better Technology for Reliable Drug Development

  3 January 2022

Read more

Genoskin launches spatial skin biology platform MANTIS®

  6 December 2021

Read more

Dr. Nicolas Gaudenzio is appointed Chief Scientific Officer at Genoskin

  8 November 2021

Read more

De-risking antiaging trials with ex vivo skin models

  28 October 2021

Read more

Genoskin launches the ISR platform®

  6 July 2021

Read more

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals

  15 June 2021

Read more

Injection site reactions platform

  10 June 2021

Read more

Interview with Pr. Guy Serre

  9 June 2021

Read more

Using NativeSkin® to study poison ivy-induced dermatitis

  22 February 2021

Read more

Human connective tissue mast cells

  30 November 2020

Read more

Top things found in human skin!

  20 November 2020

Read more

A unique ex vivo perfused human skin model to test pharmacokinetic and systemic administration in human skin

  28 October 2020

Read more

Genoskin awarded the Healthtech prize “Transformons la France!”

  16 October 2020

Read more